Latest Phenols Stories
Phase 1 study to include additional cohorts with novel product candidate being developed for the treatment of neuropathic pain NEW YORK, April 16, 2015 /PRNewswire/ -- Relmada Therapeutics,
SALT LAKE CITY, April 8, 2015 /PRNewswire/ -- Phoenix PharmaLabs, Inc.
DUBLIN, April 8, 2015 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S.
WAYNE, Pa., April 7, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing
JUPITER, Fla., April 6, 2015 /PRNewswire/ -- Charleston Laboratories, Inc.
TITUSVILLE, N.J., April 2, 2015 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. (JPI) today announced it has completed the divestiture of its U.S.
- June re-launch with significantly expanded commercial resources NEWARK, Calif., April 2, 2015 /PRNewswire/ -- Depomed, Inc.
Cash Payment Resulting from First Commercial Sale of MOVANTIK(TM) (naloxegol) Tablets in the US SAN FRANCISCO, April 2, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) announced
In the news release, Egalet Announces Proposed $60 Million Offering of Convertible Senior Notes Due 2020, issued 01-Apr-2015 by Egalet Corporation over PR Newswire, we
More Images (1 images) »